What is it about?
This study investigates how a standardized berry anthocyanin‑rich extract affects human colorectal cancer cells (Caco‑2). Using cell viability, clonogenic assays, and protein analysis, the authors examined proliferation, apoptosis, and cell‑cycle regulation. The extract reduced cell growth, activated caspase‑3, and increased p21 expression in a dose‑dependent manner.
Featured Image
Photo by Joanna Kosinska on Unsplash
Why is it important?
Colorectal adenocarcinoma cells are often resistant to conventional anticancer agents. This work highlights how dietary polyphenols, specifically berry anthocyanins, can modulate intracellular ROS levels and tumor‑suppressor pathways in vitro. It contributes to understanding how food‑derived molecules may influence cancer cell behavior at the molecular level.
Perspectives
The findings are limited to an in vitro model and cannot be directly translated to clinical use. The dual role of ROS and the complexity of antioxidant supplementation in cancer require careful interpretation. Further studies are needed in additional models to clarify mechanisms and relevance in vivo.
Prof. Antonio Speciale
University of Messina
Read the Original
This page is a summary of: Berry anthocyanins reduce proliferation of human colorectal carcinoma cells by inducing caspase-3 activation and p21 upregulation, Molecular Medicine Reports, June 2016, Spandidos Publications,
DOI: 10.3892/mmr.2016.5397.
You can read the full text:
Contributors
The following have contributed to this page
